Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week High on Earnings Beat

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares hit a new 52-week high on Thursday following a stronger than expected earnings report. The stock traded as high as $39.38 and last traded at $36.8190, with a volume of 485,555 shares traded. The stock had previously closed at $32.25.

The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.46 by $0.14. The business had revenue of $895.31 million for the quarter, compared to analyst estimates of $877.76 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.72 earnings per share.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter adjusted earnings of $0.60 per share, ahead of the $0.46 consensus estimate, and revenue of $895.3 million versus expectations of $877.8 million. Revenue increased 5.1% year over year. Read More.
• Positive Sentiment: The company raised its full-year 2026 financial guidance, with its outlook described as slightly above expectations. Same-facility revenue grew 5.2%, supported by a 1.1% increase in patient days and 4.0% growth in revenue per patient day. Read More.
• Negative Sentiment: Despite beating analysts’ estimates, quarterly EPS was down from $0.72 a year earlier, a year-over-year comparison that tempers the otherwise favorable results. Read More.

Analyst Upgrades and Downgrades

ACHC has been the subject of several research analyst reports. TD Cowen upped their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Barclays lifted their target price on Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research note on Tuesday, October 6th. Finally, UBS Group lifted their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $30.69.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in ACHC. Penn Capital Management Company LLC acquired a new stake in shares of Acadia Healthcare during the third quarter worth $15,434,000. Prescott Group Capital Management L.L.C. boosted its holdings in shares of Acadia Healthcare by 40.0% in the 3rd quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company’s stock valued at $1,925,000 after buying an additional 20,000 shares during the period. Pinnacle Wealth Planning Services Inc. grew its position in shares of Acadia Healthcare by 20.7% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company’s stock valued at $88,000 after buying an additional 550 shares during the last quarter. Congress Asset Management Co. grew its position in shares of Acadia Healthcare by 20.8% during the 3rd quarter. Congress Asset Management Co. now owns 287,390 shares of the company’s stock valued at $7,903,000 after buying an additional 49,418 shares during the last quarter. Finally, WINTON GROUP Ltd raised its stake in Acadia Healthcare by 1.4% during the second quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock worth $7,543,000 after acquiring an additional 3,449 shares during the period.

Acadia Healthcare Trading Up 11.3%

The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The firm’s 50 day moving average is $29.18 and its two-hundred day moving average is $25.91. The stock has a market cap of $3.34 billion, a price-to-earnings ratio of -2.88, a price-to-earnings-growth ratio of 9.54 and a beta of 0.64.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.